Strain | % of Tumors with Phenotype |
|---|
TN | CD3−SP | DP | CD3+SP |
|---|
26 | 7.1 | 17.9 | 64.3 | 10.7 |
2978 | 14.3 | 0 | 85.7 | 0 |
2966H | 0 | 0 | 83.3 | 16.7 |
3021 | 0 | 14.3 | 57.1 | 28.6 |
Total
|
7.8
|
13.7
|
64.7
|
13.7
|
- Phenotypes were determined by flow cytometric analyses of the thymomal cells. In case cells from one tumor had more than one phenotype, the phenotype representing the majority of the tumor cells was chosen as the phenotype of the tumor. This table summarizes the data from flow cytometric analyses of 70 tumors. TN: CD3−CD4−CD8−; SP: CD4+CD8− or CD4−CD8+; DP: CD4+CD8+. Flow cytometric analyses also indicated that all tumors (except one) were Thy-1+CD24+, 65% were CD44+, 30% were CD25+, and 90% were CD5+.
